print logo
  • Username:  
    Password:  

Petition calls on Roche to cut breast cancer drug price

 Reuters 27 October 2019

A British-led petition signed by 29,000 people has demanded that Switzerland's Roche, the world's biggest maker of cancer medicines, cut the price of its expensive new breast cancer drug Kadcyla. The campaign shows the growing pressure on drug companies as a raft of promising new cancer treatments reach the market. U.S. insurers also say they are alarmed by a coming flood of cancer medicines with "astronomical price tags", while pricing rows have flared in France and Italy. (285 Words) - By Ben Hirschler

Share

Reuters_Petition calls on Roche to cut breast cancer drug price

The logo of Swiss pharmaceutical company Roche is seen at the company's headquarters in Basel April 5, 2019. Photo: REUTERS/Arnd Wiegmann

reuters logo

This content is only available to members (street press publications). Members can log in above to view full text.

Copyright Thomson Reuters. Click For Restrictions

 Other Language Versions

SNS logo
  • Website Design